Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00276536
What this trial is testing

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Breast CancerKidney CancerLymphoma+4 more
The Cleveland Clinic 35
Not applicableTemporarily pausedNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT00126503
What this trial is testing

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Study completedNCT00005851
What this trial is testing

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
Fred Hutchinson Cancer Center 11
Early research (Phase 1)Study completedNCT00004890
What this trial is testing

Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer

Who this might be right for
Drug ExtravasationKidney Cancer
BioMedicines
Early research (Phase 1)Active Not RecruitingNCT04707248
What this trial is testing

DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

Who this might be right for
Renal Cell CarcinomaOvarian Tumor
Daiichi Sankyo 179
Testing effectiveness (Phase 2)Ended earlyNCT00684996
What this trial is testing

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerRenal Cell CarcinomaStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT04773951
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Who this might be right for
MelanomaRenal CarcinomaUrothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 47
Early research (Phase 1)Active Not RecruitingNCT02950766
What this trial is testing

NeoVax Plus Ipilimumab in Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Patrick Ott, MD, PhD 19
Early research (Phase 1)Study completedNCT00625456
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Who this might be right for
MelanomaLung CancerRenal Cell Carcinoma+1 more
Jennerex Biotherapeutics 23
Early research (Phase 1)Study completedNCT01453283
What this trial is testing

Tabectedin to Treat Children and Adolescents With Cancer

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00001683
What this trial is testing

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Who this might be right for
LymphomaMelanomaNeoplasm Metastasis+1 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)WithdrawnNCT04648826
What this trial is testing

Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies

Who this might be right for
SarcomasMelanomasGerm Cell Tumors+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00421512
What this trial is testing

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Who this might be right for
Metastatic Renal Cell CarcinomaKidney Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT02859415
What this trial is testing

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

Who this might be right for
Esophageal NeoplasmsLung NeoplasmsMesothelioma+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00193258
What this trial is testing

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
SCRI Development Innovations, LLC 94
Early research (Phase 1)WithdrawnNCT00006126
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

Who this might be right for
Breast CancerKidney CancerLung Cancer+2 more
Northwestern University
Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Next Page